Condition
Acral Melanoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Acral Melanoma clinical trials that are recruiting, at sites in 2 countries (most in China (4), United States (1)). By phase: Phase 2 (3), Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Acral Melanoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining toripalimab and endostatin for treating stage II melanoma | Phase 2 | Shanghai, Shanghai Municipality and 3 other locations | Recruiting | May 11, 2025 |
| Combining Camrelizumab, Apatinib, and Temozolomide for Advanced Acral Melanoma Treatment | Phase 3 | Beijing | Recruiting | Mar 29, 2023 |
| Combination therapy for high-risk acral melanoma before surgery | Phase 2 | Beijing, Beijing Municipality | Recruiting | Aug 23, 2022 |
| Neoadjuvant treatment for advanced acral melanoma | Phase 2 | Changchun, Jilin | Recruiting | Apr 2, 2020 |
| Gene modified immune cells for treating advanced melanoma and metastatic solid tumors | Phase 1 | Duarte, California and 2 other locations | Recruiting | Oct 8, 2019 |
All recruiting trials (5)
-
Combining toripalimab and endostatin for treating stage II melanoma
This study is testing if combining a new cancer drug with another treatment can help people with stage II melanoma live longer without their cancer coming back after surgery.
-
Combining Camrelizumab, Apatinib, and Temozolomide for Advanced Acral Melanoma Treatment
This study is testing a new combination of three medications to see if it helps people with advanced acral melanoma live longer without their cancer getting worse compared to standard treatments.
-
Combination therapy for high-risk acral melanoma before surgery
This study is testing a new combination of treatments before surgery to see if it can help people with high-risk acral melanoma have better outcomes.
-
Neoadjuvant treatment for advanced acral melanoma
This study is testing a new combination treatment for patients with advanced acral melanoma to see if it helps shrink tumors before surgery.
-
Gene modified immune cells for treating advanced melanoma and metastatic solid tumors
This study is testing if modified immune cells can safely target and attack advanced melanoma and other solid tumors in patients after they receive chemotherapy.
Related topics
Quick answers
How many Acral Melanoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.